-transparent.png){kind=logo}
BN 52021 antagonized PAF-acether-induced bronchoconstriction (BC) in the guinea-pig and inhibited BC triggered by antigen in passively sensitized animals. The anti-anaphylactic activity was prevented by propranolol and may either result from an additional property of the drug, independent from PAF antagonism or from different PAF-dependent mechanisms with different responsiveness to the various antagonists.
Related Publications
B Vilain, and
V Lagente, and
C Touvay, and
S Desquand, and
J Randon, and
J Lefort, and
P Braquet, and
B B Vargaftig
October 1987,
Toxicology letters,
B Vilain, and
V Lagente, and
C Touvay, and
S Desquand, and
J Randon, and
J Lefort, and
P Braquet, and
B B Vargaftig
January 1990,
Journal of lipid mediators,
B Vilain, and
V Lagente, and
C Touvay, and
S Desquand, and
J Randon, and
J Lefort, and
P Braquet, and
B B Vargaftig
July 1986,
Prostaglandins,
B Vilain, and
V Lagente, and
C Touvay, and
S Desquand, and
J Randon, and
J Lefort, and
P Braquet, and
B B Vargaftig
August 1986,
Pharmacological research communications,
B Vilain, and
V Lagente, and
C Touvay, and
S Desquand, and
J Randon, and
J Lefort, and
P Braquet, and
B B Vargaftig
January 1987,
Agents and actions. Supplements,
B Vilain, and
V Lagente, and
C Touvay, and
S Desquand, and
J Randon, and
J Lefort, and
P Braquet, and
B B Vargaftig
December 1986,
Prostaglandins,
B Vilain, and
V Lagente, and
C Touvay, and
S Desquand, and
J Randon, and
J Lefort, and
P Braquet, and
B B Vargaftig
August 1986,
Pharmacological research communications,
B Vilain, and
V Lagente, and
C Touvay, and
S Desquand, and
J Randon, and
J Lefort, and
P Braquet, and
B B Vargaftig
October 1985,
Immunopharmacology,
B Vilain, and
V Lagente, and
C Touvay, and
S Desquand, and
J Randon, and
J Lefort, and
P Braquet, and
B B Vargaftig
January 1986,
Progress in lipid research,
B Vilain, and
V Lagente, and
C Touvay, and
S Desquand, and
J Randon, and
J Lefort, and
P Braquet, and
B B Vargaftig
December 1988,
Pharmacological research communications,
